Gleason Grade Group 4 prostate biopsy with no cancer seen on final pathology in the magnetic resonance imaging and Prostate Specific Membrane Antigen‐Positron Emission Tomography era

INTRODUCTION: The absence of prostate cancer on final surgical pathology after biopsy‐proven prostate cancer is a rare finding. CASE PRESENTATION: Case of pT0 prostate cancer following Gleason Grade Group 4 in 1 out of 12 cores from a transrectal ultrasound‐guided biopsy in a man who underwent both...

Descripción completa

Detalles Bibliográficos
Autores principales: Mookerji, Nikhile, Mittal, Rohan, Hui, Amaris, Pfanner, Tyler, Broomfield, Stacey, Dean, Luke, Adam, Benjamin, Fung, Christopher, Tamm, Alexander, Kinnaird, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622191/
https://www.ncbi.nlm.nih.gov/pubmed/37928279
http://dx.doi.org/10.1002/iju5.12614
_version_ 1785130486916448256
author Mookerji, Nikhile
Mittal, Rohan
Hui, Amaris
Pfanner, Tyler
Broomfield, Stacey
Dean, Luke
Adam, Benjamin
Fung, Christopher
Tamm, Alexander
Kinnaird, Adam
author_facet Mookerji, Nikhile
Mittal, Rohan
Hui, Amaris
Pfanner, Tyler
Broomfield, Stacey
Dean, Luke
Adam, Benjamin
Fung, Christopher
Tamm, Alexander
Kinnaird, Adam
author_sort Mookerji, Nikhile
collection PubMed
description INTRODUCTION: The absence of prostate cancer on final surgical pathology after biopsy‐proven prostate cancer is a rare finding. CASE PRESENTATION: Case of pT0 prostate cancer following Gleason Grade Group 4 in 1 out of 12 cores from a transrectal ultrasound‐guided biopsy in a man who underwent both magnetic resonance imaging and (18)F‐PSMA‐1007 Positron Emission Tomography prior to radical prostatectomy. CONCLUSION: pT0 prostate cancer is rare. The use of novel imaging modalities may help in the workup of prostate cancer.
format Online
Article
Text
id pubmed-10622191
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-106221912023-11-03 Gleason Grade Group 4 prostate biopsy with no cancer seen on final pathology in the magnetic resonance imaging and Prostate Specific Membrane Antigen‐Positron Emission Tomography era Mookerji, Nikhile Mittal, Rohan Hui, Amaris Pfanner, Tyler Broomfield, Stacey Dean, Luke Adam, Benjamin Fung, Christopher Tamm, Alexander Kinnaird, Adam IJU Case Rep Case Reports INTRODUCTION: The absence of prostate cancer on final surgical pathology after biopsy‐proven prostate cancer is a rare finding. CASE PRESENTATION: Case of pT0 prostate cancer following Gleason Grade Group 4 in 1 out of 12 cores from a transrectal ultrasound‐guided biopsy in a man who underwent both magnetic resonance imaging and (18)F‐PSMA‐1007 Positron Emission Tomography prior to radical prostatectomy. CONCLUSION: pT0 prostate cancer is rare. The use of novel imaging modalities may help in the workup of prostate cancer. John Wiley and Sons Inc. 2023-08-11 /pmc/articles/PMC10622191/ /pubmed/37928279 http://dx.doi.org/10.1002/iju5.12614 Text en © 2023 The Authors. IJU Case Reports published by John Wiley & Sons Australia, Ltd on behalf of Japanese Urological Association. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Mookerji, Nikhile
Mittal, Rohan
Hui, Amaris
Pfanner, Tyler
Broomfield, Stacey
Dean, Luke
Adam, Benjamin
Fung, Christopher
Tamm, Alexander
Kinnaird, Adam
Gleason Grade Group 4 prostate biopsy with no cancer seen on final pathology in the magnetic resonance imaging and Prostate Specific Membrane Antigen‐Positron Emission Tomography era
title Gleason Grade Group 4 prostate biopsy with no cancer seen on final pathology in the magnetic resonance imaging and Prostate Specific Membrane Antigen‐Positron Emission Tomography era
title_full Gleason Grade Group 4 prostate biopsy with no cancer seen on final pathology in the magnetic resonance imaging and Prostate Specific Membrane Antigen‐Positron Emission Tomography era
title_fullStr Gleason Grade Group 4 prostate biopsy with no cancer seen on final pathology in the magnetic resonance imaging and Prostate Specific Membrane Antigen‐Positron Emission Tomography era
title_full_unstemmed Gleason Grade Group 4 prostate biopsy with no cancer seen on final pathology in the magnetic resonance imaging and Prostate Specific Membrane Antigen‐Positron Emission Tomography era
title_short Gleason Grade Group 4 prostate biopsy with no cancer seen on final pathology in the magnetic resonance imaging and Prostate Specific Membrane Antigen‐Positron Emission Tomography era
title_sort gleason grade group 4 prostate biopsy with no cancer seen on final pathology in the magnetic resonance imaging and prostate specific membrane antigen‐positron emission tomography era
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622191/
https://www.ncbi.nlm.nih.gov/pubmed/37928279
http://dx.doi.org/10.1002/iju5.12614
work_keys_str_mv AT mookerjinikhile gleasongradegroup4prostatebiopsywithnocancerseenonfinalpathologyinthemagneticresonanceimagingandprostatespecificmembraneantigenpositronemissiontomographyera
AT mittalrohan gleasongradegroup4prostatebiopsywithnocancerseenonfinalpathologyinthemagneticresonanceimagingandprostatespecificmembraneantigenpositronemissiontomographyera
AT huiamaris gleasongradegroup4prostatebiopsywithnocancerseenonfinalpathologyinthemagneticresonanceimagingandprostatespecificmembraneantigenpositronemissiontomographyera
AT pfannertyler gleasongradegroup4prostatebiopsywithnocancerseenonfinalpathologyinthemagneticresonanceimagingandprostatespecificmembraneantigenpositronemissiontomographyera
AT broomfieldstacey gleasongradegroup4prostatebiopsywithnocancerseenonfinalpathologyinthemagneticresonanceimagingandprostatespecificmembraneantigenpositronemissiontomographyera
AT deanluke gleasongradegroup4prostatebiopsywithnocancerseenonfinalpathologyinthemagneticresonanceimagingandprostatespecificmembraneantigenpositronemissiontomographyera
AT adambenjamin gleasongradegroup4prostatebiopsywithnocancerseenonfinalpathologyinthemagneticresonanceimagingandprostatespecificmembraneantigenpositronemissiontomographyera
AT fungchristopher gleasongradegroup4prostatebiopsywithnocancerseenonfinalpathologyinthemagneticresonanceimagingandprostatespecificmembraneantigenpositronemissiontomographyera
AT tammalexander gleasongradegroup4prostatebiopsywithnocancerseenonfinalpathologyinthemagneticresonanceimagingandprostatespecificmembraneantigenpositronemissiontomographyera
AT kinnairdadam gleasongradegroup4prostatebiopsywithnocancerseenonfinalpathologyinthemagneticresonanceimagingandprostatespecificmembraneantigenpositronemissiontomographyera

Ejemplares similares